Re: Robert J. Motzer, Paul Russo, Naomi Haas, et al. Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients with Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial. Eur Urol 2021;79:334–8: PROTECTing Patients with Locally Advanced Kidney Cancer

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)e33-e34
JournalEuropean Urology
Issue number1
StatePublished - Jul 2021

ASJC Scopus subject areas

  • Urology

Cite this